首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1603420

黏合劑屏障市場規模、佔有率、成長分析、按產品、按應用、按配方、按地區 - 行業預測，2024-2031 年

Adhesion Barrier Market Size, Share, Growth Analysis, By Product (Synthetic, Natural), By Application (Gynecological Surgeries, Cardiovascular Surgeries), By Formulation (Film, Liquid) By Region - Industry Forecast 2024-2031

出版日期: 2024年11月27日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球黏合阻隔市場規模將達到6.4億美元，從2023年的6.8億美元成長到2031年的11.5億美元，預計在預測期間（2024-2031年）將成長。為0.68%）。

由於手術數量的增加、運動相關傷害的增加以及全球醫療保健支出的增加，全球黏合屏障市場預計將顯著成長。整形外科和心血管手術對黏合屏障的需求特別高，反映出外科手術的激增。在美國，騎自行車和休閒運動等活動會導致嚴重傷害，進一步增加了對手術解決方案的需求。新興國家醫療保健的快速進步，加上人口成長和可支配收入的增加，預計將推動市場擴張。然而，這個市場面臨著諸如外科手術成本高、黏合屏障的潛在副作用以及阻礙創新和廣泛採用的嚴格法規結構等挑戰。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按公司分公司分類的股份分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Baxter International Inc.（United States）
Anika Therapeutics, Inc.（United States）
Sanofi SA（France）
Medtronic plc（Ireland）
Integra LifeSciences Corporation（United States）
Atrium Medical Corporation（Getinge AB）（United States）
FzioMed, Inc.（United States）
MAST Biosurgery AG（Switzerland）
Terumo Corporation（Japan）
Johnson & Johnson（United States）
Becton, Dickinson and Company（United States）
B. Braun Melsungen AG（Germany）
Ferring Pharmaceuticals（Switzerland）
Adhesion Barrier Company（United States）
Fidia Farmaceutici SpA（Italy）
Innocoll Holdings PLC（Ireland）
Biom'Up SAS（Zimmer Biomet Holdings, Inc.）（France）
Aziyo Biologics, Inc.（United States）

結論和建議

簡介目錄

Product Code: SQMIG15B2076

Global Adhesion Barrier Market size was valued at USD 0.64 billion in 2022 and is poised to grow from USD 0.68 billion in 2023 to USD 1.15 billion by 2031, growing at a CAGR of 0.68% during the forecast period (2024-2031).

The global Adhesion Barrier Market is poised for significant growth, driven by the rising number of surgeries, increasing sports-related injuries, and growing healthcare expenditure worldwide. The demand for adhesion barriers is particularly high in orthopedic and cardiac procedures, reflecting the surge in surgical interventions. In the United States, activities like cycling and recreational sports result in substantial injuries, further fueling the need for surgical solutions. Rapid healthcare advancements in developing countries, coupled with population growth and increased disposable incomes, are expected to enhance market expansion. However, the market faces challenges, including the high cost of surgical procedures, potential side effects of adhesion barriers, and stringent regulatory frameworks that hinder technological innovation and broader adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Adhesion Barrier market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Adhesion Barrier Market Segmental Analysis

Global Adhesion Barrier Market is segmented by Product, Application, Formulation and region. Based on Product, the market is segmented into Synthetic Adhesion Barriers, (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Other Synthetic Adhesion Barriers) and Natural Adhesion Barriers (Collagen and Fibrin)), Based on Application, the market is segmented into General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, and Others. Based on Formulation, the market is segmented into Film, Liquid, and Gel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Adhesion Barrier Market

The global adhesion barrier market is driven by the rising number of surgical procedures across various domains, including general/abdominal, gynecological, cardiovascular, orthopedic, and neurological surgeries. This growing surgical volume escalates the need for effective adhesion barriers to minimize postoperative complications and adhesion formation. Additionally, heightened awareness among healthcare professionals and patients about the severe consequences of adhesions-such as pain, bowel obstruction, infertility, and organ dysfunction-further boosts demand. Technological advancements in adhesion barrier formulations, including synthetic solutions offering enhanced efficacy, biocompatibility, and extended durability, also play a crucial role in market expansion. These innovations not only improve surgical outcomes but also encourage the adoption of adhesion barriers, solidifying their importance in modern medical practices.

Restraints in the Global Adhesion Barrier Market

A significant restraint for the global adhesion barrier market is the high cost associated with these products, which limits their adoption, particularly in price-sensitive regions. Adhesion barriers, often used in surgical procedures to prevent post-operative adhesions, can significantly increase overall treatment costs, making them less accessible for patients and healthcare facilities with constrained budgets. Additionally, the stringent regulatory approval processes for medical devices in various regions can delay market entry for new adhesion barrier products, further hindering growth. Limited awareness among healthcare professionals and patients regarding the long-term benefits of adhesion barriers also contributes to lower adoption rates, particularly in emerging markets. This creates challenges for manufacturers to achieve widespread penetration and expand their market share globally.

Market Trends of the Global Adhesion Barrier Market

The global Adhesion Barrier Market is witnessing transformative trends driving its growth. A notable development is the rising adoption of bioresorbable adhesion barriers, which naturally degrade and are absorbed by the body, eliminating the need for additional surgical removal. This trend aligns with the growing demand for solutions that minimize complications and enhance patient recovery. Additionally, the market is experiencing a surge in product innovation, with companies investing heavily in research and development. These efforts focus on creating advanced adhesion barrier formulations that offer superior biocompatibility, extended efficacy, and improved usability. Together, these trends underscore the market's dynamic nature and its commitment to delivering cutting-edge solutions to meet the evolving needs of healthcare professionals and patients.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Customer & Buying Criteria Analysis
- PESTEL Analysis
Market Attractiveness Index
Pricing Analysis

Global Adhesion Barrier Market Size by Product & CAGR (2024-2031)

Market Overview
Synthetic Adhesion Barriers
- Hyaluronic Acid
- Regenerated Cellulose
- Polyethylene Glycol
- Other
Natural Adhesion Barriers
- Collagen
- Fibrin

Global Adhesion Barrier Market Size by Application & CAGR (2024-2031)

Market Overview
General/Abdominal Surgeries
Gynecological Surgeries
Cardiovascular Surgeries
Orthopedic Surgeries
Neurological Surgeries
Other

Global Adhesion Barrier Market Size by Formulation & CAGR (2024-2031)

Market Overview
Film
Liquid
Gel

Global Adhesion Barrier Market Size & CAGR (2024-2031)

North America, (Product, Application, Formulation)
- US
- Canada
Europe, (Product, Application, Formulation)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Application, Formulation)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Application, Formulation)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Application, Formulation)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anika Therapeutics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atrium Medical Corporation (Getinge AB) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FzioMed, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MAST Biosurgery AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adhesion Barrier Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fidia Farmaceutici S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innocoll Holdings PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biom'Up SAS (Zimmer Biomet Holdings, Inc.) (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aziyo Biologics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments